Literature DB >> 15099679

Perinuclear biogenesis of mutant torsin-A inclusions in cultured cells infected with tetracycline-regulated herpes simplex virus type 1 amplicon vectors.

D C Bragg1, S M Camp, C A Kaufman, J D Wilbur, H Boston, D E Schuback, P I Hanson, M Sena-Esteves, X O Breakefield.   

Abstract

TorsinA is a novel protein identified in the search for mutations underlying the human neurologic movement disorder, early onset torsion dystonia. Relatively little is understood about the normal function of torsinA or the physiological effects of the codon deletion associated with most cases of disease. Overexpression of wild-type torsinA in cultured cells by DNA transfection results in a reticular distribution of immunoreactive protein that co-localizes with endoplasmic reticulum resident chaperones, while the dystonia-related mutant form accumulates within concentric membrane whorls and nuclear-associated membrane stacks. In this study we examined the biogenesis of mutant torsinA-positive membrane inclusions using tetracycline-regulated herpes simplex virus amplicon vectors. At low expression levels, mutant torsinA was localized predominantly around the nucleus, while at high levels it was also concentrated within cytosolic spheroid inclusions. In contrast, the distribution of wild-type torsinA did not vary, appearing diffuse and reticular at all expression levels. These observations are consistent with descriptions of inducible membrane synthesis in other systems in which cytosolic membrane whorls are derived from multilayered membrane stacks that first form around the nuclear envelope. These results also suggest that formation of mutant torsinA-positive inclusions occurs at high expression levels in culture, whereas the perinuclear accumulation of the mutant protein is present even at low expression levels that are more likely to resemble those of the endogenous protein. These nuclear-associated membrane structures enriched in mutant torsinA may therefore be of greater relevance to understanding how the dystonia-related mutation compromises cellular physiology.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15099679     DOI: 10.1016/j.neuroscience.2004.01.053

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  30 in total

Review 1.  Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.

Authors:  Jean-Luc Dreyer
Journal:  Mol Biotechnol       Date:  2011-02       Impact factor: 2.695

Review 2.  Torsins: not your typical AAA+ ATPases.

Authors:  April E Rose; Rebecca S H Brown; Christian Schlieker
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-10-13       Impact factor: 8.250

Review 3.  Inherited isolated dystonia: clinical genetics and gene function.

Authors:  William Dauer
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

4.  Dimerization of the DYT6 dystonia protein, THAP1, requires residues within the coiled-coil domain.

Authors:  Cem Sengel; Sophie Gavarini; Nutan Sharma; Laurie J Ozelius; D Cristopher Bragg
Journal:  J Neurochem       Date:  2011-08-08       Impact factor: 5.372

5.  Arresting a Torsin ATPase reshapes the endoplasmic reticulum.

Authors:  April E Rose; Chenguang Zhao; Elizabeth M Turner; Anna M Steyer; Christian Schlieker
Journal:  J Biol Chem       Date:  2013-11-25       Impact factor: 5.157

6.  Motor deficits and hyperactivity in Dyt1 knockdown mice.

Authors:  Mai T Dang; Fumiaki Yokoi; Morgan A Pence; Yuqing Li
Journal:  Neurosci Res       Date:  2006-10-13       Impact factor: 3.304

7.  Functional evidence implicating a novel TOR1A mutation in idiopathic, late-onset focal dystonia.

Authors:  Nicole Calakos; Viren D Patel; Melissa Gottron; Gaofeng Wang; Khan-Nhat Tran-Viet; Danielle Brewington; John L Beyer; David C Steffens; Ranga R Krishnan; Stephan Züchner
Journal:  J Med Genet       Date:  2009-12-02       Impact factor: 6.318

8.  Imaging and therapy of experimental schwannomas using HSV amplicon vector-encoding apoptotic protein under Schwann cell promoter.

Authors:  S Prabhakar; G J Brenner; B Sung; S M Messerli; J Mao; M Sena-Esteves; A Stemmer-Rachamimov; B Tannous; X O Breakefield
Journal:  Cancer Gene Ther       Date:  2009-10-16       Impact factor: 5.987

9.  TorsinA in the nuclear envelope.

Authors:  Teresa V Naismith; John E Heuser; Xandra O Breakefield; Phyllis I Hanson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-10       Impact factor: 11.205

10.  Herpes Virus Amplicon Vectors.

Authors:  Suresh de Silva; William J Bowers
Journal:  Viruses       Date:  2009-12-01       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.